Second-line Treatment Patterns and Outcomes in Advanced HCC after Progression on Atezolizumab/Bevacizumab
JHEP REPORTS（2025）
关键词
Hepatocellular carcinoma,atezolizumab,bevacizumab,second-line therapy,immune checkpoint inhibitors,immunotherapy,tyrosine kinase inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要